Volume 4 – Number 4

Uncovering the Complexities of Retroviral Ribonuclease H Reveals its Potential as a Therapeutic Target

HIV-1 Genetic Recombination: Experimental Approaches and Observations

Street and Network Sampling in Evaluation Studies of HIV Risk-Reduction Interventions

Might the M184V Substitution in HIV-1 RT confer Clinical Benefit?

Simplification of Antiretroviral Treatment – How to Sustain Success, Reduce Toxicity and Ensure Adherence Avoiding PI Use

Excerpts from my Conversation with HIV-1 About Virus Extinction

Alfa-defensins are the Missed CD8+ Antiviral Factor

No Benefit of STI in Chronically HIV-infected Patients under Successful Therapy

HIV Guidelines

HIV Conferences